Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Improving Availability of Intranasal Naloxone — Stella

Home/Opioid Overdose/Improving Availability of Intranasal Naloxone

View on ClinicalTrials.gov

Recruiting

Back to Opioid Overdose trials

Improving Availability of Intranasal Naloxone

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

Hartford Hospital Emergency Department, Hartford, Connecticut

Olin Neuropsychiatry Research Center, Hartford, Connecticut

Key details

Sponsor

Hartford Hospital

Collaborators

Hartford HealthCare

Enrollment target

~84 participants

Started

March 2024

Primary completion

August 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

21 Years – 65 Years

Last updated June 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.